Esperer Onco Nutrition Private Limited, a active private limited company, was established on 14 March 2019 in Navi Mumbai, Maharashtra, India. Engaging in preventive health supplements within the trade sector, it holds CIN: U24299MH2019PTC322571. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3.37 Cr and a paid-up capital of ₹3.01 Cr.
Employing 18 professional, Its leadership includes Sudipta Chattopadhyay (Director), Sohilkumar Dahyabhai Tandel (Director), Raktim Chattopadhyay (Ceo). Past directors included Sudipta Chattopadhyay, Shivshankar Gangaram Bangar, Arun Dubey. It holds ₹1.06 M open charges and ₹1.00 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Office No 170, Plot No 19, Sector 19D, Satra Plaza, Vashi, Navi Mumbai, Maharashtra, 400705.
U24299MH2019PTC322571
322571
14 March 2019
₹3.37 Cr
₹3.01 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Esperer Onco Nutrition Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sudipta Chattopadhyay | Director | 20 Dec 2023 | Current |
| Sohilkumar Dahyabhai Tandel | Director | 08 Aug 2024 | Current |
| Raktim Chattopadhyay | Ceo | 03 Apr 2020 | Current |
| Riddhesh Neema | Additional Director | 20 Dec 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Director | 09 Apr 2020 | Past |
| Pramod Abcsdd | Nominee Director | 20 Dec 2023 | Past |
| Pramod Abcsdd | Director | 02 Apr 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Esperer Onco Nutrition Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 360.11% increase. The company also saw a substantial fall in profitability, with a 13.41% decrease in profit. The company's net worth Soared by an impressive increase of 80.91%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Esperer Onco Nutrition had a promoter holding of 99.01% and a public holding of 0.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,064,000.00
₹10,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 May 2025 | Hdfc Bank Limited | ₹1.06 M | Open |
| 14 Jul 2021 | Others | ₹1.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Esperer Onco Nutrition has a workforce of 18 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Esperer Onco Nutrition, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Esperer Onco Nutrition's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Esperer Onco Nutrition Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.11 Cr with Charge ID 101127909 was registered on 17 May 2025. was documented.
The activity Esperer Onco Nutrition Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.
Riddhesh Neema was appointed as a Additional Director was appointed as a Additional Director on 20 Dec 2024 & has been associated with this company since 1 year 1 day . was recorded as a recent event.
The activity A charge registered on 14 Jul 2021 via Charge ID 100459523 with Others was fully satisfied on 26 Nov 2024. was completed.
Progress on Sohilkumar Dahyabhai Tandel was appointed as a Director was appointed as a Director on 08 Aug 2024 & has been associated with this company since 1 year 4 months . was documented.
The CIN of Esperer Onco Nutrition Private Limited is U24299MH2019PTC322571.
Esperer Onco Nutrition Private Limited is headquartered at Office No 170, Plot No 19, Sector 19D, Satra Plaza, Vashi, Navi Mumbai, Maharashtra, 400705.
Esperer Onco Nutrition Private Limited was incorporated on 14 March 2019.
The current directors of Esperer Onco Nutrition Private Limited are
The primary industry of Esperer Onco Nutrition Private Limited is Trade.
Esperer Onco Nutrition Private Limited is unlisted.
The authorized capital of Esperer Onco Nutrition Private Limited is ₹3.37 Cr, and the paid-up capital is ₹3.01 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX